BA
AGN

Bristlecone Advisors’s Allergan plc AGN Stock Holding History

Bristlecone Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,255
Closed -$435K – 133
2018
Q4 		$435K Hold
3,255
– – 0.13% 111
2018
Q3 		$620K Hold
3,255
– – 0.16% 102
2018
Q2 		$543K Sell
3,255
-43
-1% -$6.9K 0.18% 98
2018
Q1 		$555K Sell
3,298
-2,075
-39% -$348K 0.19% 98
2017
Q4 		$879K Sell
5,373
-5,132
-49% -$921K 0.28% 90
2017
Q3 		$2.15M Sell
10,505
-426
-4% -$99.1K 0.7% 41
2017
Q2 		$2.66M Buy
10,931
+365
+3% +$85.8K 0.9% 31
2017
Q1 		$2.52M Buy
10,566
+650
+7% +$151K 0.88% 32
2016
Q4 		$2.08M Sell
9,916
-1,889
-16% -$391K 0.74% 40
2016
Q3 		$2.72M Sell
11,805
-145
-1% -$35.4K 0.98% 26
2016
Q2 		$2.76M Sell
11,950
-937
-7% -$216K 1.02% 25
2016
Q1 		$3.45M Buy
12,887
+920
+8% +$263K 1.37% 15
2015
Q4 		$3.74M Buy
+11,967
New +$3.56M 1.58% 11

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bristlecone Advisors's AGN Position: Q1 2019 in Review

Bristlecone Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 3,255 shares — an estimated $435K sold.

Bristlecone Advisors first reported a position in AGN in Q4 2015 and held it in 13 quarters. The position peaked at $3.74M in Q4 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Bristlecone Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Bristlecone Advisors sold 3,255 Allergan plc shares in Q1 2019, an estimated $435K.
  • Bristlecone Advisors first reported a position in Allergan plc in Q4 2015 and held it in 13 quarters.
  • Bristlecone Advisors's Allergan plc position peaked at $3.74M in Q4 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Bristlecone Advisors's 13F filing for Q1 2019, filed 23 Apr 2019.